FEATURED SPONSORS
PAST & PRESENT:

Saturday, October 13, 2018

7:00PM-11:00PM
Loews Philadelphia Hotel
1200 Market St Philadelphia, PA 19107

HONORARY CHAIR

Governor Edward G. Rendell

Governor Ed Rendell Blingo

EMCEE

Tra Thomas

Tra Thomas Headshot Blingo

Former Eagles Offensive Left Tackle
3x Pro Bowler & NFC Champion

HONOREE

Dr. Hansell Stedman

Dr. Hansell Steadman Headshot CureDuchenne

EVENT CHAIRS

Beka and Jesse Rendell  |  Tom Smith  |  Sonal and Manu Gambhir  |  Mallika and Gaurav Gambhir  |  Mechelle LaVelle  |  Becca and Martin Lehr

THE EVENT

BLINGO is going 007 for 2018! A night you don’t want to miss playing casino games with local celebrities, a premiere golden bingo round, incredible prizes and auction items. All proceeds will support the research and development of a cure for the hundreds of thousands of young boys suffering from Duchenne muscular dystrophy. Join hundreds of Philadelphians to dine, drink, enjoy a great evening to help us find a cure. We suggest you wear your best 007 attire.

2017 Blingo Highlights
  • Over 250 of Philadelphia’s socially-minded and engaged community leaders attended.
  • Blingo raised over $240K to help fund development of a CRISPR drug led by Dr. Eric Olson Founder of Exonics. After CureDuchenne’s support Exonics raised $40M to close their Series A.
  • We had Philadelphia sports heroes: Tra Thomas and Scott Williams keep the night lively.
  • There was bling, great food and amazing auction items!

WHY

Duchenne is a progressive and fatal genetic disease that causes muscle degeneration and impacts 300,000 patients, mostly boys and young men, worldwide. Most are diagnosed by age 5, lose their ability to walk by age 12, and most don’t survive beyond their mid-20s. The disorder knows no ethnic or social boundaries. CureDuchenne funded research is providing real hope to improve and save the lives of those with Duchenne.

CURE DUCHENNE

Wired Magazine Article – CRISPR

CureDuchenne is a national nonprofit that raises awareness and funds
research to find a cure for Duchenne muscular dystrophy.

Our goal is to halt the progress of the disease by bringing life-saving drugs to help all those with Duchenne. Duchenne is a multifaceted, complex disease, so CureDuchenne has been working to “treat the whole disease” with a multi-pronged approach to find treatments for the many effects that Duchenne has on the body.

CureDuchenne has funded nine projects that have advanced into human clinical trials. With CureDuchenne’s support, the first treatment for Duchenne was approved by the FDA, Sarepta’s EXONDYS 51 (eteplirsen). This treatment may lessen the effects of the disease for those with certain mutations of Duchenne, but there is still more to be done to find a cure. CureDuchenne will continue to fund impactful research until there is a cure.

The organization was founded by Debra and Paul Miller after their son was diagnosed with Duchenne. At the time, there was not an organization focused exclusively on finding treatments for Duchenne.

Learn more at CureDuchenne.org

SPONSORSHIP OPPORTUNITIES

Support through organizations such as yours, is key to investing in new drug development.
Help to save boys with Duchenne muscular dystrophy.

Sponsor Event

To secure your sponsorship, contact Meg Wood at
meg@cureduchenne.org or (207) 650-5590

LIVE AUCTION

CONTACT

Meg Wood

Eastern Director of Development
CureDuchenne
(207) 650-5590
meg@cureduchenne.org

CureDuchenne

1400 Quail Street, Suite 110
Newport Beach, CA 92660
cureduchenne.org